[1]
GunturuK., Abu-KhalafM., and SaifM., “Hepatic Failure and Hepatorenal Syndrome Secondary to Erlotinib: A Possible Etiology of Complications in a Patient with Pancreatic Cancer”, JOP, vol. 11, no. 5, pp. 484-485, Sep. 2010.